High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$429K
$429,344
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
SLNO
S
SOLENO THERAPEUTICS INC
Huang Michael F.
• Officer • Sr. VP of Clinical Development
Sell to Cover
2026-03-27
$200,365x3
|
||||||
| SLNO |
SOLENO THERAPEUTICS INC
|
Officer • Sr. VP of Clinical Development
Sell to Cover
|
2026-03-27 | $200,365x3 | S | Form 4 |
|
SLNO
S
SOLENO THERAPEUTICS INC
Manning Meredith
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-27
$228,980x3
|
||||||
| SLNO |
SOLENO THERAPEUTICS INC
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-27 | $228,980x3 | S | Form 4 |